Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clear Eyes Triple Relief is an over-the-counter (OTC) ophthalmic solution marketed by Prestige Consumer Healthcare under the Clear Eyes brand. It is a multi-action formulation designed to provide relief from three common ocular symptoms: redness, dryness, and irritation. The product contains naphazoline hydrochloride, a sympathomimetic amine that acts as a vasoconstrictor by stimulating alpha-adrenergic receptors in the conjunctival arterioles, thereby reducing ocular congestion and redness. Additionally, the formulation includes glycerin and polysorbate 80, which function as demulcents and lubricants. These ingredients provide a protective film over the ocular surface, helping to soothe irritation and alleviate discomfort associated with dry eyes and environmental factors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on naphazoline hydrochloride + glycerin + polysorbate 80.